

CRISPR by Design with Benjamin Oakes
Feb 20, 2024
Ben Oakes, Scribe Therapeutics cofounder and CEO, discusses his journey in genome editing, transforming bacterial immune systems into genome editing tools. They explore the challenges of engineering these molecules and the potential for life-changing therapeutics. Topics include the intersection of engineering and biology, advancements in gene editing for chronic conditions, and the role of luck in discoveries.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Exploring Early Days at Jennifer Doudna's Lab and the CRISPR Impact
01:58 • 2min
Engineering CRISPR Systems for Precise Genome Editing
03:38 • 15min
Exploring Single-Payer Systems, International Medical Innovations, and Strategic Partnerships in Medicine
19:03 • 3min
Advancements in Gene Editing for Chronic Conditions
22:06 • 3min
Navigating the Lab to Market Journey and the Role of Luck in Discoveries
25:16 • 4min